Skip to main content
. 2015 Dec 16;310(6):F466–F476. doi: 10.1152/ajprenal.00288.2015

Fig. 13.

Fig. 13.

Evaluation of renal function and blood pressure in the murine CKD model before and after AAV9(HO-1) administration. A: plasma BUN levels were measured in mice, all of which were previously subjected to CKD and then administered either control AAV9(revHO-1) vector or AAV9(HO-1) vector. B: systolic blood pressure was measured in mice, all of which were previously subjected to CKD, and then administered either control AAV9(revHO-1) vector or AAV9(HO-1) vector. Measurements were performed in CKD mice, before (baseline) and 2 wk and 3 wk after the administration of control AAV9(revHO-1) vector or AAV9(HO-1) vector; n = 5 and n = 6 in AAV9(revHO-1) and AAV9(HO-1), respectively. No significant difference in either of these indexes was detected in response to AAV9(HO-1) at any time point.